Dynamic Changes of Serum Heart Type-Fatty Acid Binding Protein in Cancer Patients Treated With Immune Checkpoint Inhibitors

Objective: Immune checkpoint inhibitors (ICIs) are effective anti-cancer drugs that can improve survival in cancer patients, but their use may be associated with adverse cardiovascular side effects. Therefore, there is a clinical unmet need to identify non-invasive biomarker to detect subclinical ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Ming, Zang, Li, Xu, Aiqing, Gong, Mengqi, Liu, Qing, Huo, Bin, Wang, Jinhuan, Fu, Huaying, Tse, Gary, Roever, Leonardo, Li, Guangping, Wang, Haitao, Liu, Tong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517171/
https://www.ncbi.nlm.nih.gov/pubmed/34658887
http://dx.doi.org/10.3389/fphar.2021.748677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517171/
https://www.ncbi.nlm.nih.gov/pubmed/34658887
http://dx.doi.org/10.3389/fphar.2021.748677

Ejemplares similares